JWJiahe Wang

Jiahe Wang

*This is an algorithmically generated author record based on publicly available information.

Jiahe Wang has a total of 4 co-authors. Here are the top co-authors by number of shared publications:

  • Guanyu Wang

    Laboratory of Biocomplexity and Engineering Biology, Department of Biomedical Engineering, School of Medicine, The Chinese University of Hong Kong, Shenzhen 518172, China; CUHKSZ-STEM Joint Laboratory of Precision Medicine, The Chinese University of Hong Kong, Shenzhen 518172, China; Ciechanover Institute of Precision and Regenerative Medicine, School of Medicine, The Chinese University of Hong Kong, Shenzhen 518172, China

    1 shared publication
  • Imran Sajid

    Guangdong Basic Research Center of Excellence for Aggregate Science, School of Science and Engineering,Chinese University of Hong Kong, Shenzhen,Shenzhen,China, China

    1 shared publication
  • Javed Akhtar

    Provincial Hospital Affiliated to Shandong University

    1 shared publication
  • Muhammad Imran

    Department of Computer Science,Institute of Southern Punjab,Multan,Pakistan, Pakistan

    1 shared publication

Latest Publications

  • Open Access

    Single-Cell FRET Imaging: A Robust Biophysical Platform to Resolve Heterogeneity in Metabolic Dysfunction and Cancer Drug Resistance

    by Javed Akhtar, Muhammad Imran, Jiahe Wang, Imran Sajid, Guanyu Wang

    Cells with similar endpoint measurements can have different biochemical response histories. Time-lapse single-cell Förster resonance energy transfer (FRET) imaging can distinguish these histories and test their relationship to metabolic function and cancer-cell fate. We connect FRET biophysics, biosensor design, and quantitative measurement to interpret cellular heterogeneity in metabolic dysfunction and cancer drug resistance. We emphasize corrected sensitized emission FRET imaging, distinguish corrected ratios from physical transfer efficiency, and describe controls for reporter specificity, temporal fidelity, and reproducibility. In metabolism, FRET imaging can reveal graded or bistable behavior and characterize sensitivity, response amplitude, history dependence, and coupling between signaling and substrate handling. In cancer, time-lapse signaling measurements paired with independent cell-fate outcomes can distinguish incomplete inhibition, adaptive recovery, and survival despite sustained pathway suppression. Cell culture, organoid, and intravital studies illustrate these capabilities and limits. Linking calibrated response histories to independent functional outcomes provides a robust foundation for candidate dynamic biomarkers. Integrating trajectory features with molecular profiles using machine learning could identify candidate predictors of treatment response. Future studies should test whether these dynamic features improve compound selection, combination design, and treatment schedules beyond baseline activity, initial inhibition, and endpoint measurements, with validation in independent patient-derived and in vivo models.